Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EMA And FDA Co-Operate To Reduce GMP Inspections Burden

This article was originally published in The Pink Sheet Daily

Executive Summary

EMA and FDA are offering to conduct joint GMP inspections for certain manufacturing sites, but pharma has been slow to respond.

You may also be interested in...



FDA Plans To Rely On Non-U.S. Regulators In Global Drug Quality Initiative

FDA restructures its staff as it prepares for new U.S.-EU mutual reliance activities to enhance pharmaceutical quality, but it offers few details on upcoming plans.

FDA Plans To Rely On Non-U.S. Regulators In Global Drug Quality Initiative

FDA restructures its staff as it prepares for new U.S.-EU mutual reliance activities to enhance pharmaceutical quality, but it offers few details on upcoming plans.

FDA Launches Global Rx Quality Initiative With Plans To Rely On Non-U.S. Regulators

Agency restructures staff as it prepares for new U.S.-EU mutual reliance activities to enhance pharmaceutical quality but offers few details on upcoming plans.

Related Content

Topics

UsernamePublicRestriction

Register

PS071040

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel